Baxter International, the US-headquartered maker of a broad set of injectable and infusion medicines, announced it will buy Claris Injectables, a wholly owned subsidiary of Claris LifesciencesBSE 9.86 %, for $625...
Malvinder and Shivinder Singh in talks with TPG Capital to sell 26% in Fortis
Cash-strapped brothers Malvinder and Shivinder Singh are in active discussions with private equity group TPG Capital to sell a significant minority stake in Fortis Healthcare. The transaction may also see the folding...
Pharma cos to drive growth, diversify products via M&As: Moody’s
Indian drugmakers will engage in more mergers and acquisitions (M&As) in the next two years to deepen geographic and product diversity, says US research and risk analysis firm Moody’s Investors Service. Indian...
Lonza says in talks to buy Capsugel; deal could top $5 billion – sources
Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems...
Abbott Files Suit to Terminate $5.8 Billion Alere Purchase
Abbott Laboratories filed suit to terminate its $5.8 billion purchase of Alere Inc., citing setbacks since the deal was signed in January that it says have significantly eroded the value of the medical-test maker. The...
Takeda’s talks to acquire Valeant’s Salix stall: sources
Takeda Pharmaceutical Co Ltd’s (4502.T) negotiations to acquire Valeant Pharmaceuticals International Inc’s (VRX.TO) Salix stomach-drug business have stalled over price disagreements, people familiar with...
Indegene Lifesystems acquires Enicma Group for Rs 109 crore
MUMBAI: Healthcare IT firm Indegene Lifesystems has acquired US-based Enicma Group for $16 million (Rs 109.54 crore) to ramp up its analytics and omni-channel digital solutions capability for the pharma industry. Manish...
Pinfold Overseas acquires 6.42 stake in Morepen Laboratories
NEW DELHI: Pinfold Overseas has acquired 6.42 per cent additional stake in pharmaceutical firm Morepen LaboratoriesBSE 0.84 %. The company, which already had 2.14 per cent stake in the pharma firm, purchased additional...
J&J makes takeover approach for Swiss drugmaker Actelion: Bloomberg
U.S. healthcare company Johnson & Johnson (JNJ.N) has approached Swiss biotechnology firm Actelion Ltd (ATLN.S) about a potential takeover, Bloomberg reported on Thursday, citing people it said were familiar with...
Aurobindo Pharma scouts for acquisitions in Europe
Hyderabad: Aurobindo Pharma Ltd is scouting for acquisitions in Europe to gain a foothold in the market. “I would not comment on the specifics, but as we had mentioned in the past also, it is predominantly two large...
Sun Pharma to acquire 85 per cent stake in Russia’s Biosintez
MUMBAI: India’s largest drug maker Sun PharmaBSE -0.90 %, facing an uncertain US market over pricing issues, launched an attempt to move into emerging markets and announced on Wednesday the acquisition of Biosintez, a...
Cipla divests 16.7 per cent stake in Chase Pharma to Allergan
MUMBAI: Drug maker Cipla’s UK arm sold the entire 16.7% stake it held in Chase Pharma, a US-based clinical-stage biopharmaceutical company, to Allergan, famous for its Botox brand, the drug maker said. CiplaBSE -0.89 %...
